Company Sugentech Inc.

Equities

A253840

KR7253840003

Medical Equipment, Supplies & Distribution

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sales per region

Sector Diagnostic & Testing Substances

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-04-29 pm EDT			5-day change	1st Jan Change
5,460 ^KRW	-0.36%		-3.36%	-29.55%

2023	Tranche Update on Sugentech Inc.'s Equity Buyback Plan announced on March 29, 2023.	CI
2023	Tranche Update on Sugentech Inc.'s Equity Buyback Plan announced on March 29, 2023.	CI

Sugentech Incorporate is a Korea-based company mainly engaged in the production and sale of in-vitro diagnostic test reagents. The Company is involved in the manufacturing and sale of in vitro diagnostic test reagents, point-of-care testing (POCT) products, folic acid products under the name of SOLGAR, as well as molecular diagnostic reagents. The in vitro diagnostic test reagents are for personal use and are sold under the name SUREARLY. The POCT products are for professional use and are sold under the name INCLIX. In addition, the Company is engaged in therapeutic drug monitoring, as well as drug analysis method development. The Company distributes its products within the domestic market and to overseas markets, including Indonesia.

Number of employees: 137

KRW in Million	2022	Weight	2023	Weight	Delta
Bio/Device 100.0 %	-	-	7,132	100.0 %	-

KRW in Million	2022	Weight	2023	Weight	Delta
South Korea 71.4 %	78,308	77.2 %	5,089	71.4 %	-93.50%
Asia 17.2 %	15,060	14.9 %	1,230	17.2 %	-91.83%
Other (Outside North America) 10.7 %	1,329	1.3 %	762	10.7 %	-42.68%
Europe 0.5 %	3,289	3.2 %	36	0.5 %	-98.92%
South America 0.2 %	3,413	3.4 %	16	0.2 %	-99.55%

Managers	Title	Age	Since
Seong-Bum Yoo FOU	Founder	57	11-12-08
Eun-Kyung Kim FOU	Founder	49	11-12-08
Mi-Jin Sohn FOU	Founder	59	11-12-08
Jong-Yoon Park DFI	Director of Finance/CFO	46	-
Jae-Hong Jeon AUD	Comptroller/Controller/Auditor	49	-

Members of the board	Title	Age	Since
Mi-Jin Sohn FOU	Founder	59	11-12-08
Jong-Yoon Park DFI	Director of Finance/CFO	46	-
Seong-Bum Yoo FOU	Founder	57	11-12-08
Kang-Min Heo BRD	Director/Board Member	60	-

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	16,722,608	14,247,973 ( 85.20 %)	0	85.20 %
Stock B	0	12,315	0	0

Name	Equities	%	Valuation
Mi-Jin Sohn 10.24 %	1,712,380	10.24 %	8 M ₩
Seong-Bum Yoo 3.255 %	544,326	3.255 %	3 M ₩
Soo-jin Koo 0.3673 %	61,430	0.3673 %	291 122 ₩
Won-gon Kim 0.3249 %	54,340	0.3249 %	257 522 ₩
Jae-gyun Kim 0.1830 %	30,600	0.1830 %	145 016 ₩
Mi-boon Son 0.1441 %	24,100	0.1441 %	114 212 ₩
Yu-jin Lee 0.1120 %	18,730	0.1120 %	88 763 ₩
Dimensional Fund Advisors Ltd. 0.0464 %	7,767	0.0464 %	36 809 ₩
DFA Australia Ltd. 0.001423 %	238	0.001423 %	1 128 ₩
Kang-Min Heo 0.000000 %	0	0.000000 %	- ₩

Sugentech, Inc.

Unit 216, Migun Techno World II 187 Techno 2-ro

34025, Daejeon

http://www.sugentech.com

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Medical Equipment, Supplies & Distribution

Diagnostic & Testing Substances

	1st Jan change	Capi.
SUGENTECH INC.	-29.55%	60.83M
BIOMÉRIEUX	-0.60%	12.95B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-9.59%	7.84B
DIASORIN S.P.A.	+1.82%	5.5B
AUTOBIO DIAGNOSTICS CO., LTD.	+0.02%	4.61B
LANTHEUS HOLDINGS, INC.	+7.52%	4.61B
10X GENOMICS, INC.	-47.94%	3.4B
ANDON HEALTH CO., LTD.	+6.42%	2.66B
VITROLIFE AB	-14.59%	2.08B
MYRIAD GENETICS, INC.	+1.72%	1.79B

Diagnostic & Testing Substances